TSXV - Delayed Quote CAD

Aurora Spine Corporation (ASG.V)

0.2900 +0.0150 (+5.45%)
At close: April 26 at 2:59 PM EDT
Key Events
Loading Chart for ASG.V
DELL
  • Previous Close 0.2750
  • Open 0.3000
  • Bid 0.2800 x --
  • Ask 0.2950 x --
  • Day's Range 0.2900 - 0.3000
  • 52 Week Range 0.2300 - 0.4650
  • Volume 45,000
  • Avg. Volume 12,422
  • Market Cap (intraday) 21.945M
  • Beta (5Y Monthly) 0.64
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0400
  • Earnings Date Apr 29, 2024 - May 3, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Aurora Spine Corporation, through its subsidiary, Aurora Spine, Inc., engages in the development and distribution of minimally invasive interspinous fusion systems and devices in Canada. The company offers interspinous process lumbar fusion devices, such as the ZIP, ZIP ULTRA, ZIP LP, and ZIP-51 for patients suffering from degenerative disc diseases; and Ti-Coated polyether ether ketone interbody cages, which provide spacing and stability between the vertebrae while bone grows to complete the fusion process. It also provides sterile-packed titanium plasma spray coated spinal infusion implants for bone growth, as well as interbody products, such as EOS, VOX, Echo, Echo SD, and EchoXL for the lumbar section of the spine, and discovery for cervical procedures. In addition, the company provides SOLO, an anterior lumbar interbody fusion 3D printed stand-alone fusion device, which is an integrated plate and spacer system that helps to preserve the natural anatomic profile while providing spinal column support and stability; and SiLo, a posterior fusion device for the sacroiliac joint. Further, it offers DEXA-C, a cervical interbody system, which is a porous 3D-printed intervertebral body fusion device that incorporates low-, mid-, or high-density lattice pattern options to support the matching of patients' bone quality, as well as DEXA SOLO-L spinal fusion system. Aurora Spine Corporation was founded in 2013 and is headquartered in Toronto, Canada.

www.aurora-spine.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ASG.V

Aurora Spine Grants Stock Options

Aurora Spine Grants Stock Options

Performance Overview: ASG.V

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ASG.V
27.50%
S&P/TSX Composite index
4.82%

1-Year Return

ASG.V
3.57%
S&P/TSX Composite index
7.48%

3-Year Return

ASG.V
61.84%
S&P/TSX Composite index
15.01%

5-Year Return

ASG.V
14.71%
S&P/TSX Composite index
32.54%

Compare To: ASG.V

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ASG.V

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    21.95M

  • Enterprise Value

    26.47M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.03

  • Price/Book (mrq)

    4.29

  • Enterprise Value/Revenue

    1.88

  • Enterprise Value/EBITDA

    -27.60

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -15.86%

  • Return on Assets (ttm)

    -11.50%

  • Return on Equity (ttm)

    -51.12%

  • Revenue (ttm)

    14.09M

  • Net Income Avi to Common (ttm)

    -2.23M

  • Diluted EPS (ttm)

    -0.0400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    373.38k

  • Total Debt/Equity (mrq)

    98.47%

  • Levered Free Cash Flow (ttm)

    73.53k

Company Insights: ASG.V

People Also Watch